Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Target Cell Response to Hormones01:22

Target Cell Response to Hormones

3.1K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
3.1K
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

4.1K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.1K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

174
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
174
Regulation of Hormone Secretion01:19

Regulation of Hormone Secretion

3.4K
Regulation of hormone secretion is a finely tuned orchestration driven by various types of stimuli, encompassing neural, humoral, and hormonal signals. Environmental cues instigate neural stimuli, where action potentials traverse nerve fibers to reach their designated targets. An illustrative scenario is the body's response to stress, wherein the sympathetic nervous system releases epinephrine from the adrenal glands, inducing the well-known 'fight or flight' reaction.
Humoral...
3.4K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

4.6K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.6K
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

In Vitro Percutaneous Absorption of Permeation-Enhancing Estrogen Formulations.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Testosterone Therapy for Late-Onset Hypogonadism: A Clinical, Biological, and Analytical Approach Using Compounded Testosterone 0.5-20% Topical Gels.

Pharmaceutics·2024
Same author

Treatment Options for Male Hypogonadism.

International journal of pharmaceutical compounding·2024
Same author

Hormone Treatment Options for Males: What to do for Men with Low Testosterone.

International journal of pharmaceutical compounding·2024
Same author

Major Study Affirming the Relative Safety of Testosterone-replacement Therapy.

International journal of pharmaceutical compounding·2023
Same author

Establishing a Rationale for Compounding Hormone Replacement Therapy.

International journal of pharmaceutical compounding·2018

相关实验视频

Updated: Jul 4, 2025

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.2K

建立复合激素替代疗法的理由

Bruce Biundo1

  • 1Professional Compounding Centers of America, Houston, Texas. bbiundo@pccarx.com.

International journal of pharmaceutical compounding
|February 2, 2024
PubMed
概括

复合生物相同激素提供独特的,患者特定的选择超越商业产品. 药剂师利用对雌激素受体α和β的日益增长的知识来定制激素治疗.

科学领域:

  • 内分泌学 在内分泌学.
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 医生和从业人员询问复合生物相同激素的必要性和独特性.
  • 激素替代疗法的市场格局已经演变,有新的商业选择可供选择.

研究的目的:

  • 为了解决围绕复合生物相同激素的问题.
  • 突出复合疗法的独特优势,与商业产品相比.
  • 强调了解激素受体亚型的重要性.

主要方法:

  • 审查当前的商业激素产品.
  • 分析复合药剂师的独特能力.
  • 整合关于雌激素受体亚型 (α和β) 的新兴知识.

主要成果:

  • 现在有商业产品含有生物相同的雌激素和孕激素.
  • 复合药剂师提供患者特定的配方.
  • 在理解雌激素受体β方面取得了重大进展.

结论:

  • 复合生物相同激素提供个性化的解决方案.
  • 对雌激素受体亚型的越来越多的理解提高了治疗策略.

更多相关视频

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:27

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

738
Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration
06:51

Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration

Published on: June 7, 2012

57.6K

相关实验视频

Last Updated: Jul 4, 2025

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.2K
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:27

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

738
Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration
06:51

Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration

Published on: June 7, 2012

57.6K
  • 复合在激素治疗定制方面具有明显的优势.